Abstract
Cachexia is rarely observed in patients with advanced prostate cancer treated with combined androgen blockade. Androgens play an important role in the regulation of body mass composition and influence the secretion of leptin, the appetite regulating hormone. The aim of the study was to assess the influence of a combined treatment with nonsteroidal antiandrogen and LH-RH analogue on the hormonal regulation of appetite and changes in body mass in patients with advanced prostate cancer (Whitmore-Jewett stage D1 or D2). Eighteen patients with prostate cancer and 17 healthy subjects matched for age and body mass index were included. In all patients serum concentrations of leptin, neuropeptide Y (NPY), insulin, testosterone and estradiol were measured before and after four and twelve weeks of androgen blockade. Pretreatment serum leptin levels were similar in patients with prostate cancer and in the controls. In a multiple regression analysis only body mass index and testosterone significantly contributed to the variation of plasma leptin. During the treatment body mass and plasma leptin significantly increased while NPY decreased. The change of plasma NPY was significant only after 4 weeks of therapy. This study shows that the afferent regulation of leptin secretion is unchanged in advanced prostate cancer. Androgen ablation significantly increases body mass and influences secretion of appetite regulating hormones. Testosterone appears to play a significant role in the regulation of leptin secretion.
Similar content being viewed by others
References
Denis L. Prostate cancer. Primary hormonal treatment. Cancer 1993, 71 (Suppl.): 1050–1058.
Kirby R.S. Recent advances in the medical management of prostate cancer. Br. J. Clin. Pract. 1996, 50: 88–93.
Eisenberger M.A., Crawford E.D., Wolf M., et al. Prognostic factors in stage D2 prostate cancer: important implications for future trials: results of a cooperative group study (INT.0036). Semin. Oncol. 1994, 21: 613–619.
Kirby R.S., Watson A., Newling D.W.W. Prostate cancer and sexual function. Pros. Canc. Pros. Dis. 1998, 1: 179–184.
Trachtenberg J. Innovative approaches to the hormonal treatment of advanced prostate cancer. Eur. Urol. 1997, 32 (Suppl. 3): 78–80.
Zhang Y., Proenca R., Maffei M., Barone M., Lori L., Friedman J.M. Positional cloning of the mouse obesity gene and its human homologue. Nature 1994, 372: 425–432.
Simons J.P., Schols A.M., Campfield L.A., Wouters E.F., Saris W.H. Plasma concentration of total leptin and human lung-cancer-associated cachexia. Clin. Sci. Colch. 1997, 93: 273–277.
Wallace A.M., Sattar N., McMillan D.C. Effect of weight loss and the inflammatory response on leptin concentrations in gastrointestinal cancer patients. Clin. Cancer Res. 1998, 4: 2977–2979.
Mantzoros C.S., Bolhke K., Moschos S., Cramer D.W. Leptin in relation to carcinoma in situ of the breast: a study of pre-menopausal cases and controls. Int. J. Cancer 1999, 80: 523–526.
Auwerx J., Staels B. Leptin. Lancet 1998, 351: 737–742.
Tan J.T., Patel B.K., Kaplan L.M., Koenig J.L., Hooi S.C. Regulation of leptin expression and secretion by corticosteroids and insulin. Implications for body weight. Endocrine 1998, 8: 85–92.
Havel P.J., Kasim-Karakas S., Dubuc G.R., Mueller W., Phinney S.D. Gender differences in plasma leptin concentrations. Nature Med. 1996, 2: 949–950.
Ambrosius W.T., Compton J.A., Bowsher R.R., Pratt J.H. Relation of race, age, and sex hormone differences to serum leptin concentrations in children and adolescents. Horm. Res. 1998, 49: 240–246.
Machinal F., Dieudonne M.N., Leneveu M.C., Pecquery R., Giudicelli Y. In vivo and in vitro ob gene expression and leptin secretion in rat adipocytes: evidence for a regional specific regulation by sex steroid hormones. Endocrinology 1999, 40: 1567–1574.
Wabitsch M., Blum W.F., Muche R., et al. Contribution of androgens to the gender difference in leptin production in obese children and adolescents. J. Clin. Invest. 1997, 100: 808–813.
Behre H.M., Simoni M., Nieschlag E. Strong association between serum levels of leptin and testosterone in men. Clin. Endocrinol. (Oxf.) 1997, 47: 237–240.
Escobar-Morreale H.F., Serrano-Gotarredona J., Varela C., Garcia-Robles R., Sancho J.M. Circulating leptin concentrations in women with hirsutism. Fertil. Steril. 1997, 68: 898–906.
Laughlin G.A., Morales A.J., Yen S.S. Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsu-linemia. J. Clin. Endocrinol. Metab. 1997, 82: 1692–1696.
Luukkaa V., Pesonen U., Huhtaniemi I., et al. Inverse correlation between serum testosterone and leptin in men. J. Clin. Endocrinol. Metab. 1998, 83: 3243–3246.
Jockenhovel F., Blum W.F., Vogel E., et al. Testosterone substitution normalizes serum leptin in hypogonadal men. J. Clin. Endocrinol. Metab. 1997, 82: 2510–2513.
Elbers J.M., Asscheman H., Seidell J.C., Frolich M., Meinders A.E., Gooren L.J. Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals. J. Clin. Endocrinol. Metab. 1997, 82: 3267–3270.
Stephens T.W., Basinski M., Bristow P.K. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995, 377: 530–532.
Dagogo-Jack S., Fanelli C., Paramore D., Brothers J., Landt M. Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes 1996, 45: 695–698.
Kiess W., Blum W.F., Aubert M.L. Leptin, puberty and reproductive function: lessons from animal studies and observations in humans. Eur. J. Endocrinol. 1998, 138: 26–29.
Haffner S.M., Miettinen H., Karhapaa P., Mykkanen L., Laakso M. Leptin concentration, sex hormones, and cortisol in nondiabetic men. J. Clin. Endocrinol. Metab. 1997, 82: 1807–1809.
Shimizu H., Ohtani K.I., Uehara Y., et al. Orchiectomy and response to testosterone in the development of obesity in young Otsuka-Long-Evans-Tokushima Fatty (OLETF) rats. Int. J. Obes. Relat. Metab. Disord. 1999, 22: 318–324.
Pinilla L., Seoane L.M., Gonzales L. Regulation of serum leptin by gonadal function in rats. Eur. J. Endocrinol. 1999, 140: 468–473.
McCann S.M., Kimura M., Walczewska A., Karanth S., Rettori V., Yu W.H. Hypothalamic control of gonadotrophin secretion by LHRH, FSHRF, NO, cytokines, and leptin. Domest. Anim. Endocrinol. 1998, 15: 333–344.
Lagiou P., Signorello L.B., Trichopoulos D., Tzonou A., Trichopoulou A., Mantzoros C.S. Leptin in relation to prostate cancer and benign pro-static hyperplasia. Int. J. Cancer 1998, 76: 25–28.
Dotsch J., Adelmann M., Englaro P., et al. Relation of leptin and neuropeptide Y in human blood and cerebrospinal fluid. J. Neurol. Sci. 1997, 151: 185–188.
Boden G., Chen X., Kolaczyski J.W., Polansky M. Effects of prolonged hyperinsulinemia on serum lep-tin in normal human subjects. J. Clin. Invest. 1997, 100: 1107–1113.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nowicki, M., Bryc, W. & Kokot, F. Hormonal regulation of appetite and body mass in patients with advanced prostate cancer treated with combined androgen blockade. J Endocrinol Invest 24, 31–36 (2001). https://doi.org/10.1007/BF03343805
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03343805